-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.P1.70 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster I

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Haixia Fu*, Meng Lv, MD, PhD, Yuanyuan Zhang*, Tingting Han*, Xiao-Dong Mo*, Fengrong Wang, MD*, Chenhua Yan*, Jun Kong*, Yu Wang*, Yuqian Sun, MD*, Wei Han*, Huan Chen*, Yao Chen*, Yu-Hong Chen*, Lanping Xu, MD, PhD*, Kaiyan Liu, MD, PhD, Xiaojun Huang* and Xiaohui Zhang*

Peking University People’s Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Liang Piu Koh, MBBS, MRCP1*, Michelle Limei Poon, MBBS, MRCP2*, Jeffrey Quek, MBBS3*, Lip Kun Tan, MBBS, FRCP, FRCPath4*, Rajat Bhattacharyya5*, Michaela Su-Fern Seng, MBBS5*, Zi Yi Lim, MB ChB6*, Poh Lin Tan, MBBS7*, Colin Phipps Diong, MB BCh BAO8*, Balamurugan Vellayappan, MBBS9*, Ah Moy Tan, MD5*, Joanne Lee, MBBS10*, William YK Hwang, MBBS, FRCP(London), MMed(Int Med), FAMS11*, Hein Than, MD, FRCPath, MRCP3, Aloysius Ho, MBBS, MRCP, FRCPath12*, Ian QH Wu, MBBS, MRCP13,14*, Yang Liang Boo, MD, MRCP15, Yvonne SM Loh, MBBS, MRCP16*, Teck Guan Soh17*, Gina Gan3*, Kheng Wei Yeoh, MBBS, MSc, MRCP, MPH, FRCR (Clinical Oncology)18*, Wen Shen Looi, MBBS19*, Bryan SH Ho, MBBS19*, Yin Jie Koh20,21*, Wing Y. Leung22,23* and Yeh Ching Linn, MBBS, MRCP3*

1National University Cancer Institute, Singapore, Singapore
2National University Cancer Insitute, Singapore, National University Hospital, Singapore, Singapore
3Department of Hematology, Singapore General Hospital, Singapore, Singapore
4Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
5Department of Paediatrics, KK Women’s and Children’s Hospital, Singapore, Singapore
6Center for Clinical Hematology, Mount Elizabeth Novena Medical Center, Singapore, Singapore
7Department of Paediatrics, National University Hospital, Singapore, Singapore
8Parkway Cancer Center, Mount Elizabeth Novena Medical Center, Singapore, Singapore
9Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore
10National University Hospital, Singapore, Singapore
11Haematology, Singapore General Hospital and National Cancer Centre, Singapore, Singapore
12Department of Haematology, Singapore General Hospital, Singapore, AL, SGP
13Department of Haematology-Oncology, National University Cancer Institute, 119704, Singapore
14Sengkang General Hospital, singapore, Singapore
15Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia
16Curie Oncology, Singapore, Singapore
17Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
18Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore
19National Cancer Center Singapore, Singapore, Singapore
20National University Cancer Institute, Singapore, Singapore, Singapore
21University College London, London, United Kingdom
22Department of Paediatrics, KK Women's and Children Hospital, Singapore, Singapore
23The University of Hong Kong, Hong Kong, HKG

Arata Ishii1*, Akira Yokota, MD, PhD2*, Emiko Sakaida, MD, PhD3, Shokichi Tsukamoto, MD, PhD4, Katsuhiro Shono, MD, PhD2*, Takashi Toya5, Yuho Najima6, Takeshi Kobayashi, MD7, Noriko Doki7, Hideki Nakasone, MD, PhD8, Shinichi Kako9, Takayoshi Tachibana, MD10*, Masatsugu Tanaka11*, Nobuyuki Aotsuka, MD, PhD12*, Toru Sakura, PhD, MD13*, Shingo Yano, MD, PhD14, Shin Fujisawa15*, Yuki Shiko16*, Yoshihito Ozawa17*, Chiaki Nakaseko, MD, PhD18 and Yoshinobu Kanda, MD, PhD8,19

1Department of Hematology, Chiba University Hospital, Chiba-Shi, CHI, Japan
2Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
3Division of Hematology, Department of Hematology, Chiba University Hospital, Chiba City, Japan
4Department of Hematology, Chiba University Hospital, Chiba, Japan
5Hematology division, The University of Tokyo, Tokyo, Japan
6Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Tokyo, TKY, Japan
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
8Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama City, Japan
9Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
10Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
11Department of Hematology, Kanagawa Cancer Center, Yokohama, KAN, Japan
12Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan
13Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan
14Division of Clinical Oncology and Hematology, Jikei University School of Medicine, Tokyo, Japan
15Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
16Biostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba, Japan
17Biostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba-shi, Japan
18Department of Hematology, International University of Health and Welfare, Narita, Japan
19Division of Hematology, Jichi Medical University, Shimotsuke, Japan

Yasuyuki Arai, MD, PhD, FACP1, Yoshiko Atsuta2*, Ruta Brazauskas, PhD3,4*, Naya He, MPH4*, Shahrukh Hashmi, MD, MPH5,6*, Leslie E. Lehmann, MD7, William A. Wood, MD, MPH8, Hemalatha G. Rangarajan, MD9, Shingo Yano, MD, PhD10, Shinichi Kako11, Masamitsu Yanada, MD12*, Yukiyasu Ozawa13*, Noriko Doki14*, Yoshinobu Kanda, MD, PhD15, Takahiro Fukuda16*, Yuta Katayama, MD, PhD17, Tatsuo Ichinohe18, Junji Tanaka, MD, PhD19, Junya Kanda, MD, PhD20, Takanori Teshima, M.D., Ph.D.21, Shinichiro Okamoto, MD, PhD22 and Wael Saber, MD, MS4

1Department of Hematology and Oncology, Kyoto University Hospital, Kyoto, Japan
2The Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
3Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI
4CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
5Department of Internal Medicine, Mayo Clinic, Rochester, MN
6Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates
7Dana Farber Cancer Institute/Boston Children's Hospital, Boston, MA
8Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC
9Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Childrens Hospital, Columbus, OH
10Division of Clinical Oncology and Hematology, Jikei University School of Medicine, Tokyo, Japan
11Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
12Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan
13Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
14Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
15Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama City, Japan
16Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
17Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan
18Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
19Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan
20Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
21Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
22Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

Alex Hoover, MD1, John E Wagner, MD2, Michael R Verneris, MD3 and Christen L. Ebens, MD, MPH2

1Division of Pediatric Hematology/Oncology, University of Minnesota, Minneapolis, MN
2Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN
3Children's Hospital Colorado, University of Colorado At Denver, Aurora, CO

Kyung Taek Hong, MD1*, Hyun Jin Park, MD2*, Bo Kyung Kim, MD3*, Hong Yul An, MD2*, Jung Yoon Choi, MD2* and Hyoung Jin Kang, MD, PhD4

1Department of Pediatrics, Seoul National University Cancer Research Institute, Seoul National University College of medicine, Seoul, South Korea
2Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, Korea, Republic of (South)
3Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, Korea, Republic of (South)
4Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children’s Hospital, Seoul, South Korea

Elif Ince, MD1*, Jacques-Emmanuel Galimard, PhD2*, Marianne Ifversen, MD, PhD3*, Arnaud Dalissier, PhD4*, Zofia Szmit, MD, PhD5*, Franco Locatelli, MD6, Oana Mirci-Danicar, MD7*, Petr Sedlacek, MD, PhD8*, Jean-Hugues Dalle, MD, PhD9*, Mouhab Ayas, MD10, Rose-Marie Hamladji, MD, PhD11*, Andrea Biondi, MD12, Jan Styczynski, MD, PhD13, Yves Bertrand, MD, PhD14*, Elena Skorobogatova, MD, PhD15*, Abdelghani Tbakhi, MD16*, Katrine Kielsen, MD, PhD3*, Vassiliki Kitra-Roussou, MD17*, Franca Fagioli, MD18*, Wolfgang Holter, MD19*, Andreas H Groll, MD20*, Mahmoud Aljurf, MD21, Mervi Taskinen, MD, PhD22*, Marc Bierings, MD, PhD23, Roland Meisel, MD24, Simone Cesaro, MD25*, Krzysztof Kalwak, MD, PhD5* and Selim Corbacioglu, MD26

1Ankara University Medical Faculty, Department of Pediatric Hematology and BMT Unit, Ankara, TUR
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
3Copenhagen University Hospital Rigshospitalet, Department of Paediatric and Adolescent Medicine, Copenhagen, Denmark
4EBMT Paris Study Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
5Department of Pediatric Hematology/Oncology and BMT Wroclaw Medical University, Wroclaw, Poland
6Department of Pediatric Hematology and Oncology IRRCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
7Bristol Royal Hospital for Children, Bristol, United Kingdom
8University Hospital Motol, Department of Paediatric Haematology And Oncology, Prague, Czech Republic
9Pediatric Hematology and Immunology Department, Robert Debre Hospital, GHU APHP Nord-Université de Paris Cité, Paris, France
10Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Middle, Saudi Arabia
11Centre Pierre et Marie Curie, Alger, Algeria
12Pediatric Bone Marrow Transplant Unit, Fondazione MBBM -Milano Bicocca University, Monza, Italy
13University Hospital, Collegium Medicum UMK Department of Pediatric Hematology and Oncology, Bydgoszcz, Poland
14Institut d`Hematologie et d`Oncologie Pediatrique,Unité de coordination interne et externe, Lyon, France
15The Russian Children´s Research Hospital Department of Bone Marrow Transplantation, Moscow, Russian Federation
16King Hussein Cancer Centre, Amman, Jordan
17St Sophia Children`s Hospital Oncology Centre “MARIANNA V. VARDINOGIANNIS – ELPIDA”, BMT Unit, Athens, Greece
18Onco-Ematologia Pediatrica, Centro Trapianti Cellule Staminali, Ospedale Infantile Regina Margherita, Torino, Italy
19St. Anna Kinderspital, Stem Cell Transplantation Unit, Vienna, Austria
20University Children’s Hospital Muenster, Department of Pediatric Hematology/Oncology and Center for Bone Marrow Transplantation, Muenster, Germany
21King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
22Hospital for Children and Adolescents, Helsinki University Hospital and Helsinki University, Helsinki, Finland
23Princess Maxima Center/ University Hospital for Children (WKZ), Stem cell transplantation, Utrecht, Netherlands
24Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
25Pediatric Hematology Oncology Unit, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
26Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany

Yosra M. Aljawai, MD, MS1, Hua-Ling Tsai2*, Ravi Varadhan, PhD2*, Richard J. Jones, MD2 and Philip H. Imus, MD2

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, WASHINGTON, DC
2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Zaihong Shen*, Jun Yang, MD*, Yu CAI*, Liping Wan, MD*, Chongmei Huang, MD*, Xiaowei Xu, MD*, Jiahua Niu*, Xinxin Xia*, Chang Shen*, Huiying Qiu*, Kun Zhou*, Yin Tong* and Xianmin Song, MD, PhD

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Veronika Schneider, Dr.1*, Karin Melanie Cabanillas Stanchi, Dr.1*, Karina Althaus2,3*, Sarah Schober, Dr.1*, Sebastian Michaelis, Dr.1*, Christian M. Seitz, Dr.1*, Peter Lang, Dr.1*, Rupert Handgretinger, Dr.1, Tamam Bakchoul, MD2,4, Stefanie Hammer, Dr.2,4* and Michaela Döring, Dr.1*

1Dpt. I - General Pediatrics, Hematology and Oncology, University Children's Hospital Tübingen, Tübingen, Germany
2Center for Clinical Transfusion Medicine ZKT GmbH, Tübingen, Germany
3University Hospital of Tuebingen, Institute for Clinical and Experimental Transfusion Medicine (IKET), Tübingen, Germany
4Institute for Clinical and Experimental Transfusion Medicine, University Hospital Tübingen, Tübingen, Germany

Idoroenyi Amanam, MD1, Salman Otoukesh, MD2*, Dongyun Yang, PhD3*, Syed Rahmanuddin, MD4*, Brian J Ball, MD5, Monzr M. AL Malki, MD6,7,8,9, Ryotaro Nakamura, MD1*, Guido Marcucci, MD1, Stephen J Forman, MD1, Haris Ali, MD1 and Vinod A. Pullarkat, MD1*

1Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
4Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA
5Department of Hematology/HCT, City of Hope National Medical Center, Pasadena, CA
6Department of Hematologic Malignancies Translational Science and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope, Duarte, CA
7City of Hope National Medical Center, Duarte, CA
8HLA Laboratory, Department of Hematology and HCT, City of Hope, Medical Center, Duarte, CA
9Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA

Zhiyong Peng, MD1*, Sa Zong1*, Litao Huang2*, Yang Sun1*, Yanru Pei1*, Zimao Lu1*, Chunfu Li, MD1, Li Yue1* and Jun Zhou1*

1Nanfang-Chunfu Children's Institute of Hematology, Taixin Hospital, Dongguan, China
2Institute of Forensic Medicine, Southern Medical University, Guangzhou, China

María Queralt Salas, MD1*, Paola Charry2*, Pedro Puerta-Alcalde3*, Nuria Martínez-Cibrian, MD4*, Mariana Chumbita3*, Tommaso Francesco Aiello3*, Marc Brusosa5*, María Teresa Solano4*, Anna Serrahima6*, Joan Cid7*, Miquel Lozano, PhD4*, Jordi Arcarons4*, Noemí Llobet8*, Laura Rosinol Dachs9*, Jordi Esteve, MD, PhD4, Álvaro Urbano-Ispizua, MD, PhD4, Enric Carreras, MD, PhD10*, Carolina García-Vidal3*, Maria Carmen Martinez Munoz, PhD4*, Francesc Fernández-Avilés, MD4*, María Suárez-Lledó, MD4* and Montserrat Rovira, MD, PhD4*

1Hematopoietic Transplantation Unit and Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
2Hospital Clinic de Barcelona, Barcelona, Spain
3Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain
4Hematopoietic Transplantation Unit and Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
5University of Barcelona, Barcelona, Spain
6Hematopoietic Cell Transplant Program, Hospital Clinic de Barcelona, Barcelona, Alabama, ESP
7Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, ICMHO, IDIBAPS, Hospital Clínic, Barcelona, Spain
8Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, IDIBAPS, Josep Carreras Research Institute, Hospital Clínic, Barcelona, Spain
9Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
10Josep Carreras Institute against leukemia (Campus Clinic), Barcelona, Spain

Lanping Xu, MD, PhD1,2,3*, Yue Lu4*, Jing Chen, DO5, Shuwen Sun6*, Shaoyan Hu, MD, PhD7, Shunqing Wang, MD, PhD8*, Xuedong Wu, MD, PhD9*, Yuan Sun10*, Dingming Wan, MD11*, Yajing Xu, MD&PhD12, Hui Jiang, MD, PhD13*, Chunfu Li, MD14, Mei Lan, MD15*, Erlie Jiang, PhD16*, Fei Li17*, Sixi Liu, MD, PhD18*, Yongmin Tang, MD19, Fan Lin3*, Peihua Lu, MD20,21*, Chengjuan Luo22* and Xiaojun Huang23,24*

1National Clinical Research Center for Hematologic Disease, Beijing, AL, China
2Peking University Institute of Hematology, Beijing, China
3Peking University People's Hospital, Beijing, China
4Bone Marrow Transplant Department, Hebei Yanda Lu Daopei Hospital, Langfang, China
5Department of Hematology/Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Hangzhou, CO, China
6West China Second University Hospital, Sichuan University / West China Women’s and Children’s Hospital, Chengdu, China
7Department of Pediatric Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China
8Department of Hematology, Guangzhou First People's Hospital, Guangzhou, China
9Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China
10Department of Hematology, Beijing Jingdu Children's Hospital, Beijing, China
11Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
12Department of hematology, Xiangya hospital, Central South University, Changsha, China
13Children's Hospital of Shanghai, Shanghai Jiao Tong University, Shanghai, China
14Nanfang-Chunfu Children's Institute of Hematology & Oncology, Taixin Hospital, Dongguan, China
15The People’s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Naning, China
16Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
17The First Affiliated Hospital of Nanchang University, Nanchang, China
18Department of Hematology -Oncology, Shenzhen Children's Hospital, Shenzhen, China
19Department of Hematology & Oncology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China
20Hebei Yanda Lu Daopei Hospital, Langfang, China
21Beijing Lu Daopei Institute of Hematology, Beijing, China
22Shanghai Children's Medical Center, Shanghai, China
23Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Beijing, China
24Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China

Peter A. Von Dem Borne1, Berit M. Kemps-Mols2*, Liesbeth C. de Wreede, PhD3*, Adriaan A. van Beek2*, Tjeerd J.F. Snijders, MD PhD4*, Danielle van Lammeren5, Janneke Tijmensen6*, Aniko Sijs-Szabo1*, Theo L. Nering Bögel1*, Mirjam A. Oudshoorn1*, Constantijn J.M. Halkes, MD, PhD1, Peter van Balen1, Erik WAF Marijt, MD, PhD1, Jennifer M.L. Tjon, MD, PhD1*, Joost S.P. Vermaat, MD, PhD1 and Hendrik Veelken, MD, PhD1

1Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands
3Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands
4Medisch Spectrum Twente, Enschede, Netherlands
5Department of Hematology, Haga Ziekenhuis, The Hague, Netherlands
6Reinier de Graaf Gasthuis, Delft, Netherlands

Xinhui Zheng1*, Mingyang Wang2*, Aiming Pang3* and Erlie Jiang, PhD1*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Cent, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, Tianjin, China

Mohamad Mohty, MD PhD1, Franco Locatelli, MD2, Didier Blaise, MD, PhD3, Regis Peffault De Latour4*, Myriam Labopin, MD5*, Hélène Labussière-Wallet, MD6*, Vian Amber7*, Virginie Gandemer8*, Deborah Gutierrez9*, Nalina Dronamraju10*, Jean-Hugues Dalle, MD, PhD11 and Ibrahim Yakoub-Agha12*

1EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France
2IRCCS Ospedale Pediatrico Bambino Gesú, Catholic University of the Sacred Heart, Rome, Italy
3Institut Paoli-Calmettes, Aix Marseille Université, Management Sport Cancer Laboratoire (MSC), Marseille, France
4Assistance Publique–Hôpitaux de Paris, Saint-Louis Hospital, Université Paris Cité, Paris, France
5EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
6Department of Hematology, Hopital Lyon Sud, Lyon, France
7Jazz Pharmaceuticals, Oxford, United Kingdom
8University Hospital of Rennes, Rennes, France
9Jazz Pharmaceuticals, Lyon, France
10Jazz Pharmaceuticals, Philadelphia, PA
11Hôpital Robert-Debré, GHU APHP Nord et Université de Paris Cité, Paris, France
12CHU de Lille, Université de Lille, INSERM U1286, Infinite, Lille, France

Moniek de Witte1*, Jorinde Hoogenboom2*, Jarl Mooyaart3*, Christian Chabannon, MD-PhD4, Florent Malard, MD, PhD5*, Annalisa Ruggeri, MD, PhD6* and Jurgen Kuball, MD7

1University Medical Center Utrecht, Department of Hematology, Utrecht, NLD
2CTIWP of EBMT, Leiden, Netherlands
3EBMT Statistical Unit, Leiden, Netherlands
4Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France
5Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, INSERM UMRs 938, Centre de Recherche Saint-Antoine (CRSA), Paris, France
6Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
7University Medical Centre Dept. of Haematology, Utrecht, The Netherlands, Utrecht, Netherlands

Poonkuzhali Balasubramanian, MSc, PhD1, Aswin Anand PAI, MSc2*, Rajesh Nagarajan, B.Sc3*, Stephanie Hughes4*, Eunice Sindhuvi Edison, PhD5*, Uday Prakash Kulkarni, MD1*, Aby Abraham, MD, DM6*, Alok Srivastava7, Vikram Mathews, MD, DM6 and Biju George, MD, DM5

1Department of Haematology, Christian Medical College, Vellore, India
2Christian Medical College- Vellore, VELLORE, TAMIL NADU, India
3Christian Medical College Vellore, Vellore, India
4InsightRx, San Francisco
5Department of Haematology, Christian Medical College, Vellore, Tamilnadu, India
6Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India
7Department of Hematology, Christian Medical College, Vellore, India

Melhem Solh, MD1, Scott R. Solomon, MD1, Xu Zhang, PhD2*, Lawrence E. Morris Jr., MD1*, Lizamarie Bachier-Rodriguez, MD1*, H. Kent Holland, MD1 and Asad Bashey, MD, PhD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2Center for Clinical and Transitional Sciences, University of Texas Health Science Center, Houston, TX

Lucas Maahs, MD1, Karen Sweiss, PharmD2, Pritesh Patel3, Sally Campbell-Lee, MD4*, Nadim Mahmud, MBBS, PhD5, Victor R. Gordeuk, MD6, Damiano Rondelli, MD3 and Santosh L. Saraf, MD7

1Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
2Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
3Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
4Department of Pathology, University of Illinois at Chicago, Chicago
5Division of Hematology/Oncology, Department of Medicine, Univ. of Illinois at Chicago, Chicago, IL
6Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Carol Stream, IL
7University of Illinois Hospital & Health Sciences System, Willowbrook, IL

Fieke W Hoff, MD, PhD1, Prapti A. Patel, MD2*, Stephen S. Chung, MD3, Naveen Premnath, M.D.4*, Jude Khatib, MD2, Mirjana Tadic-Ovcina5*, Abeer AhmedRabie6*, Debra Helton1*, Jaime Shahan, PA-C1*, Courtney Dryden1*, Hetalkumari Patel, PharmD, BCOP7*, Afrough Aimaz2*, Praveen Ramakrishnan Geethakumari, MD, MS6, Robert H. Collins, M.D.8, Madhuri Vusirikala, MD6* and Yazan F. Madanat, MD8

1UT Southwestern Medical Center, Dallas, TX
2Division of Hematologic Malignancies, University of Texas Southwestern Medical Center, Dallas, TX
3Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
4Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
5UT Southwestern Medical Center, Dallas
6Division of Hematologic Malignancies, UT Southwestern Medical Center, Dallas, TX
7Department of Pharmacy, UT Southwestern Medical Center, Dallas, TX
8Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX

*signifies non-member of ASH